Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Results 1 - 20 of about 60 for Genentech
Company Exchange Symbol Last price Quote change Market cap
PDL BioPharma Inc NASDAQ PDLI 6.72 +0.11 (1.66%) 1.09B
PDL BioPharma, Inc. (PDL) is a biotech company. The Company is engaged in managing a portfolio of patents and royalty assets, consisting primarily of its ...
Genentech, Inc. Private
... human growth hormone Nutropin, cystic fibrosis drug Pulmozyme, and asthma drug Xolair. Genentech is wholly owned by Swiss pharma powerhouse Roche.
Biogen Inc NASDAQ BIIB 402.92 +10.04 (2.56%) 93.22B
Biogen Inc., formerly Biogen Idec Inc., is a global biotechnology company. The Company discovers, develops, manufactures and markets therapies for the ...
Array Biopharma Inc NASDAQ ARRY 7.74 +0.25 (3.34%) 1.07B
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients ...
Roche Holding AG ETR RHO5 106.90 -0.45 (-0.42%) 0.00
Roche Holding AG is a Switzerland-based pharmaceuticals and diagnostics company. It discovers, develops and provides diagnostic and therapeutic products and ...
ImmunoGen, Inc. NASDAQ IMGN 9.03 +0.10 (1.12%) 785.73M
ImmunoGen, Inc. is a biotechnology company. The Company develops targeted anticancer therapeutics. The Company has three wholly-owned product candidates in ...
PDL BIOPHARMA INC. DL-,01 FRA PDL 6.11 -0.03 (-0.44%)
ARRAY BIOPHARMA DL-,001 FRA AR2 7.22 +0.22 (3.19%)
BIOGEN INC. DL -,0005 FRA IDP 370.89 +12.22 (3.41%)
BIOGEN INC. DL -,0005 ETR IDP 369.60 +3.60 (0.98%)
Biogen Idec SWX BIIB 377.80 0.00 (0.00%)
IMMUNOGEN INC. DL-,01 FRA IMU 8.20 +0.06 (0.79%)
Exelixis, Inc. NASDAQ EXEL 3.29 +0.14 (4.44%) 639.51M
Exelixis, Inc., is a biotechnology company. The Company is engaged in developing small molecule therapies for the treatment of cancer.
SPDR S&P Emerging Middle Est & Afrca ETF NYSEARCA GAF 68.52 -0.17 (-0.25%) 48.16M
SPDR S&P Emerging Middle East & Africa ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P/Citigroup BMI Middle ...
SPDR EURO STOXX 50 ETF NYSEARCA FEZ 39.85 +0.62 (1.58%) 3.37B
SPDR EURO STOXX 50 ETF (the Fund) seeks to replicate as closely as possible the price and yield of the EURO STOXX 50 Index (the Index).
SPDR DJ Wilshire Global Real Estate(ETF) NYSEARCA RWO 48.75 +0.39 (0.81%) 2.01B
SPDR Dow Jones Global Real Estate ETF (the Fund), formerly SPDR DJ Wilshire Global Real Estate ETF, seeks to replicate as closely as possible the price and ...
SPDR S&P China (ETF) NYSEARCA GXC 99.04 -0.02 (-0.02%) 1.45B
SPDR S&P China ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P/Citigroup BMI China Index (the Index).
NewLink Genetics Corp NASDAQ NLNK 43.36 +1.62 (3.88%) 1.21B
NewLink Genetics Corporation (NewLink) is a biopharmaceutical company focused on discovering, developing and commercializing immunotherapeutic products for ...
SPDR S&P Emerging Latin America (ETF) NYSEARCA GML 49.23 -0.09 (-0.18%) 34.52M
SPDR S&P Emerging Latin America ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P/Citigroup BMI Latin America ...
SPDR Dow Jones Interntnl Real Estate ETF NYSEARCA RWX 44.20 +0.11 (0.25%) 5.26B
SPDR Dow Jones International Real Estate ETF (the Fund), formerly SPDR DJ Wilshire International Real Estate ETF, seeks to closely match the returns and ...